Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis: Laboratory investigation

Journal of Neurosurgery

Volumn 118, Issue 4, 2013, Pages 846-853

  Gao, Huasong ^a,b   Yu, Bin ^a,b   Yan, Yaohua ^a   Shen, Jianhong ^a   Zhao, Sanhu ^c   Zhu, Jianhong ^d   Qin, Wenxin ^b   Gao, Yilu ^a  

^a NANTONG UNIVERSITY   (China)

^b SHANGHAI CANCER INSTITUTE   (China)

^c SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

ANXA2; CALR; Glioma; Oncology; PGAM 1; Prognosis

Indexed keywords

ANXA2 PROTEIN; CALR PROTEIN; PGAM1 PROTEIN; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; GLIOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RAT;

ANIMALS; ANNEXIN A2; BRAIN NEOPLASMS; CALRETICULIN; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; PHOSPHOGLYCERATE MUTASE; PROGNOSIS; RATS; RATS, SPRAGUE-DAWLEY; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION;

EID: 84875823848     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.9.JNS112134     Document Type: Article

References (29)

1. Alur M, Nguyen MM, Eggener SE, Jiang F, Dadras SS, Stern J, et al: Suppressive roles of calreticulin in prostate cancer growth and metastasis. Am J Pathol 175:882-890, 2009
2. An JH, Lee SY, Jeon JY, Cho KG, Kim SU, Lee MA: Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J Proteome Res 8:2873-2881, 2009
3. Bai DS, Dai Z, Zhou J, Liu YK, Qiu SJ, Tan CJ, et al: Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology 49:460-470, 2009
4. Bao H, Jiang M, Zhu M, Sheng F, Ruan J, Ruan C: Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol 90:177-185, 2009
5. Bolteus AJ, Berens ME, Pilkington GJ: Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep 1:225-232, 2001
6. Chen CN, Chang CC, Su TE, Hsu WM, Jeng YM, Ho MC, et al: Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer. Ann Surg Oncol 16:524-533, 2009
7. Du XL, Yang H, Liu SG, Luo ML, Hao JJ, Zhang Y, et al: Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma. Oncogene 28:3714-3722, 2009
8. Duncan R, Carpenter B, Main LC, Telfer C, Murray GI: Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98:426-433, 2008
9. Emoto K, Sawada H, Yamada Y, Fujimoto H, Takahama Y, Ueno M, et al: Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 21 (2B):1339-1345, 2001
10. Gillette JM, Chan DC, Nielsen-Preiss SM: Annexin 2 expression is reduced in human osteosarcoma metastases. J Cell Biochem 92:820-832, 2004
11. Hsu WM, Hsieh FJ, Jeng YM, Kuo ML, Chen CN, Lai DM, et al: Calreticulin expression in neuroblastoma-a novel independent prognostic factor. Ann Oncol 16:314-321, 2005
12. Huang LJ, Chen SX, Huang Y, Luo WJ, Jiang HH, Hu QH, et al: Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer. Lung Cancer 54:87-94, 2006
13. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al: Cancer statistics, 2005. CA Cancer J Clin 55:10-30, 2005
14. Kim DM, Noh HB, Park DS, Ryu SH, Koo JS, Shim YB: Immunosensors for detection of Annexin II and MUC5AC for early diagnosis of lung cancer. Biosens Bioelectron 25:456-462, 2009
15. Ludwig N, Keller A, Heisel S, Leidinger P, Klein V, Rheinheimer S, et al: Improving seroreactivity-based detection of glioma. Neoplasia 11:1383-1389, 2009
16. Lwin ZM, Guo C, Salim A, Yip GW, Chew FT, Nan J, et al: Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Mod Pathol 23:1559-1566, 2010
17. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al: Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54-61, 2007
18. Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K, Tachibana M: Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer 101:287-294, 2009
19. Ren F, Wu H, Lei Y, Zhang H, Liu R, Zhao Y, et al: Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma. Mol Cancer 9:81, 2010
20. Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B: Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs 17:1533-1545, 2008
21. Shiozawa Y, Havens AM, Jung Y, Ziegler AM, Pedersen EA, Wang J, et al: Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 105:370-380, 2008
22. Sun H, Liu J, Ding F, Wang X, Liu M, Gu X: Investigation of differentially expressed proteins in rat gastrocnemius muscle during denervation-reinnervation. J Muscle Res Cell Motil 27:241-250, 2006
23. Trojanowicz B, Sekulla C, Lorenz K, Köhrle J, Finke R, Dralle H, et al: Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma. Mol Cell Endocrinol 325:110-117, 2010
24. Turhani D, Krapfenbauer K, Thurnher D, Langen H, Fountoulakis M: Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27:1417-1423, 2006
25. Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Aldape K, et al: Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev 13:461-467, 2004
26. Xie LQ, Zhao C, Cai SJ, Xu Y, Huang LY, Bian JS, et al: Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening. J Proteome Res 9:4701-4709, 2010
27. Yonglitthipagon P, Pairojkul C, Chamgramol Y, Mulvenna J, Sripa B: Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker. Int J Parasitol 40:1203-1212, 2010
28. Zhao P, Zhang W, Tang J, Ma XK, Dai JY, Li Y, et al: Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 101:387-395, 2010
29. Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N, Kroemer G: Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res 16:3100-3104, 2010